APA (7th ed.) Citation

IN, M., GW, R., R, F., T, O., Y, V., NE, K., . . . LC, H. (2025). Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement. Blood advances, 9(16), 4081. https://doi.org/10.1182/bloodadvances.2024015779

Chicago Style (17th ed.) Citation

IN, Muhsen, et al. "Outcomes of Brexucabtagene Autoleucel in Patients with Relapsed/refractory Acute Lymphoblastic Leukemia with CNS Involvement." Blood Advances 9, no. 16 (2025): 4081. https://doi.org/10.1182/bloodadvances.2024015779.

MLA (9th ed.) Citation

IN, Muhsen, et al. "Outcomes of Brexucabtagene Autoleucel in Patients with Relapsed/refractory Acute Lymphoblastic Leukemia with CNS Involvement." Blood Advances, vol. 9, no. 16, 2025, p. 4081, https://doi.org/10.1182/bloodadvances.2024015779.